Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nensi Shrestha

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Pharmacology|May 28, 2020
Does Crizotinib Auto-Inhibit CYP3A in vivo?Abigail R Bland, Nensi Shrestha, Rhonda J Rosengren, et al.
Current Cancer Drug Targets|January 7, 2022
Experimental Determination of Cancer Drug Targets with Independent Mechanisms of ResistanceAbigail R Bland, Nensi Shrestha, Maddie Berry, et al.
International Journal of Nanomedicine|July 24, 2023
Short-Term Intravenous Administration of Carbon Nano-Onions is Non-Toxic in Female MiceYi Zhen Tan, Lucy R Thomsen, Nensi Shrestha, et al.
F1000Research|August 27, 2019
Does the mouse tail vein injection method provide a good model of lung cancer?Nensi Shrestha, Zabeen Lateef, Orleans Martey, et al.
Scientific Reports|February 18, 2016
Interaction of EGFR to δ-catenin leads to δ-catenin phosphorylation and enhances EGFR signalingYongfeng He, Taeyong Ryu, Nensi Shrestha, et al.
Molecules and Cells|April 10, 2018
δ-Catenin Increases the Stability of EGFR by Decreasing c-Cbl Interaction and Enhances EGFR/Erk1/2 Signaling in Prostate CancerNensi Shrestha, Hridaya Shrestha, Taeyong Ryu, et al.
Biochimica Et Biophysica Acta|June 19, 2016
Investigation of the molecular mechanism of δ-catenin ubiquitination: Implication of β-TrCP-1 as a potential E3 ligaseHridaya Shrestha, Tingting Yuan, Yongfeng He, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Pharmacology|May 28, 2020
Does Crizotinib Auto-Inhibit CYP3A in vivo?Abigail R Bland, Nensi Shrestha, Rhonda J Rosengren, et al.
Current Cancer Drug Targets|January 7, 2022
Experimental Determination of Cancer Drug Targets with Independent Mechanisms of ResistanceAbigail R Bland, Nensi Shrestha, Maddie Berry, et al.
International Journal of Nanomedicine|July 24, 2023
Short-Term Intravenous Administration of Carbon Nano-Onions is Non-Toxic in Female MiceYi Zhen Tan, Lucy R Thomsen, Nensi Shrestha, et al.
F1000Research|August 27, 2019
Does the mouse tail vein injection method provide a good model of lung cancer?Nensi Shrestha, Zabeen Lateef, Orleans Martey, et al.
Scientific Reports|February 18, 2016
Interaction of EGFR to δ-catenin leads to δ-catenin phosphorylation and enhances EGFR signalingYongfeng He, Taeyong Ryu, Nensi Shrestha, et al.
Molecules and Cells|April 10, 2018
δ-Catenin Increases the Stability of EGFR by Decreasing c-Cbl Interaction and Enhances EGFR/Erk1/2 Signaling in Prostate CancerNensi Shrestha, Hridaya Shrestha, Taeyong Ryu, et al.
Biochimica Et Biophysica Acta|June 19, 2016
Investigation of the molecular mechanism of δ-catenin ubiquitination: Implication of β-TrCP-1 as a potential E3 ligaseHridaya Shrestha, Tingting Yuan, Yongfeng He, et al.
Pageof 1